Category Archives: Neuroscience

11 Animals That Have Changed the History of Neurological Science – Interesting Engineering

Whatever your views on animal testingfor scientific research, they have helped us make some very real breakthroughs in our understanding in fields like neuroscience. By getting to grips with the basic fundamentals of certain aspects of biology using animal analogs for humans, we have been able to harvest various therapeutic solutions and potential cures for some very serious diseases and disorders.

Most of this was only made possible thanks to the sacrifice made by countless animal stand-ins for human beings. If you don't agree with animal testing, perhaps you could volunteer your own living body (and mind) for research purposes in the future?

Yeah, we thought so.

RELATED: 11 INTERESTING DISCOVERIES OF THE BRAIN OVER THE PAST TEN YEARS

Which animals have had the biggest influence on neurological science?

So, without further ado, here are some of the most important animals in the history of neuroscience. This list is far from exhaustive and is in no particular order.

Rodents, like rats, are one of the most important animals used in a vast swathe of scientific research -- especially in the field of neuroscience. In fact, rats have been used for scientific research for more than 200 years.

After the mid-1980s, when companion animals like cats were phased out, rodents like rats became the go-to animal model for a lot of neuroscientific research.

As instruments became progressively smaller thanks to miniaturization, rats became ideal testbeds for research. Rodents, like rats, also have relatively short lifespans, enabling research into aging and its effects on the nervous system convenient and time-efficient for scientific studies.

Studies on rats have provided insights into neural regeneration, intelligence studies, and many other breakthroughs in science. To date, thirty Noble Prizes in science have been awarded based on research using rats.

While rabbits are primarily used for studying toxicity and safety testing of substances like drugs, chemicals, or medical devices, they have also proved to be vitally important for neuroscientific research.

In fact, one of the earliest scientific breakthroughs came thanks to the work of Louis Pasteur. He is particularly well-renowned for his work on a vaccine for rabies.

This highly contagious infection devastates a host's nervous system and enters the body through being bitten by infected animals or through saliva entering through an open wound.

"When an extract from the spinal column of a rabid dog was injected into healthy animals, symptoms of rabies appeared. By studying the tissues of infected rabbits, Pasteur was able to produce an attenuated form of the virus, which he later used to develop a vaccine against the disease. " - understandinganimalresearch.org.uk.

Much like rats, mice have been a "workhouse" of scientific research, especially in neuroscience. Mice actually form somewhere in the region of 75% of all animal research and, amazingly, have comparable human genes in 98% of their genome.

For the very same reasons as rats are now a very common test animal for research, they are very important to neuroscientific research today.

Mice have very similar reproductive and nervous systems to human beings and suffer from many of the same diseases. From cancer to anxiety, mice are very useful test-animals for finding human treatments for various disorders.

Dogs are not only one of the first domesticated animals, but they have allowed us to make leaps and bounds in our understanding of neuroscience. Apart from research into human-dog bonding, the psychological rehabilitative benefits of dogs with heart-failure patients, research on dogs have helped with some important treatments for major diseases.

One example was a 2012 study into the use of cell transplants for treating spinal cord injury. The trial was conducted on pet dogs with spinal injuries and showed some very interesting results.

Pigs have historically been another important animal in scientific research. With regard to neuroscience, studies on pigs have led to some major breakthroughs in various areas.

One of the most notable was the identification of hypothalamic hormones. Back in the 1950s, research by Roger Guillemain and Andrew von Schally identified that the hypothalamus was responsible for hormonal release from the pituitary gland.

This research was directly transferrable to human beings and allowed researchers and clinicians to make important discoveries into the endocrine system and how it relates to some diseases. They won the Nobel prize for this work in 1977.

Monkeys are another incredibly important group of animals for neuroscientific research. They have a very close similarity to human beings genetically, and physiologically and so are almost perfect analogies for humans.

Some of the most notable neuroscientific breakthroughs from monkey research are significant breakthroughs in our understanding and treatment for Parkinson's disease and tremors. They make near-perfect models for the disorder and have helped develop some essential therapeutic techniques for it.

As an aside, given the current, now confirmed, global pandemic of COVID-19, monkeys, have historically played a major role in identifying and creating vaccines for other coronaviruses like SARS.

Did you know chickens are the closest living relative to certain species of dinosaur? Chickens have also proved to be vitally important for many areas of neuroscientific research. Being vertebrates their developmental process is very similar to our own.

One of the most notable has been the improvement of our understanding of the development of the nervous system.

Primarily how cells migrate and differentiate over time.

Frogs, as it turns out, have helped us understand some fundamental aspects of neuroscience. Studies on frogs helped us, for example, were used to show that nerve impulses affect the heart using a chemical transmission.

This was the first evidence of neurotransmission ever seen.

Studies on them also enabled us to uncover the fact that acetylcholine is responsible for relaying nerve impulses to animals' muscles. Frogs also helped us understand the development of things like the neural plate.

Cats have historically been used for neuroscientific research prior to the mid-1980s. They were ideal test subjects as their size, and their robust nature meant that they could withstand extensive surgery.

They are also large enough to wear or accommodate bulky instrumentation and were also inexpensive animals to breed and keep. But, in the mid-1980s new regulations regarding animal testing substantially increased the economic cost and administrative burden for lab testing on felines.

Public opinion also went against using so-called companion animals in scientific research. After this period, attention shifted more to rodents.

Research on cats has fundamentally improved our understanding of the workings of the nervous system. Most notably, how the visual system needs light to develop as well as the subtle effects of aging on the nervous system.

Ferrets are amazing creatures. They are incredibly smart and, as it turns out, have been instrumental in certain engineering projects including avionics in aircraft.

But, they have also been of great value for expanding our knowledge of neuroscience. Studies on ferrets have allowed us to understand the hypothalamic-pituitary portal system, visual and auditory systems of mammals, including humans.

They have also enabled us to help understand the size of human brains. Ferrets also make great pets, FYI.

And last, but by no means least, is the zebrafish. This incredibly useful little fish is one of the most frequently used model organisms for a lot of genetic and developmental studies.

This is because, primarily, that their embryos or transparent enabling systematic study of them fairly easy. Their entire genetic sequence was also mapped as early as 2011, and their genome has many homologs with that of humans.

With regards to neuroscience, testing on zebrafish has led to some major breakthroughs in our understanding of things like Alzheimer's disease, autism, sleep, heart disease, and some cancers.

More:
11 Animals That Have Changed the History of Neurological Science - Interesting Engineering

UCT’s neuroscience centre first of its kind – eNCA

JOHANNESBURG - The University of Cape Town and the Western Cape government are opening a groundbreaking neuroscience centre at Groote Schuur Hospital.

The new institute will fast-track novel treatments for neurological and mental disorders.

This state-of-the-art facility is a first for the continent.

It will focus on diagnosing and treating neurological challenges facing Africans.

READ: Texas hospital livestreams brain surgery on Facebook

Brain health is one of the key things that we need to protect for us to actually develop Africa in any way. Therefore the Neuroscience Institute serves as one of the first institutions that have been set up that can address local issues that affect brain health, said Rachael Dangarembizi, UCT lecturer in Neurophysiology.

The centre was conceived in 2015, and it's expected to be fully operational in May.

The idea is to get academic activities going and bring in people from a range of backgrounds, not only from the medical school and the health science faculty, but also from other campuses, said professor Graham Fieggen, UCT Neuroscience Director.

The facility won't only be treating patients.

It will provide invaluable training to UCT medical students.

See the rest here:
UCT's neuroscience centre first of its kind - eNCA

New Toolkit May Repair DNA Breaks Linked to Aging and Cancer – Interesting Engineering

Researchers at theUniversities of Sheffield and Oxford have discovered a new toolkit that may help repair DNA breaks that are linked to aging, cancer, and evenmotor neuron disease. The key to this toolkit lies in aprotein called TEX264.

RELATED:WHAT IS DNA COMPUTING, HOW DOES IT WORK, AND WHY IT'S SUCH A BIG DEAL

TEX264 has the capacity toand 'eat' toxic proteins that can stick to DNA and cause it to become damaged. This is key to preventing aging, cancer, and neurological diseases as they are caused by a string of broken DNAs.

"Failure to fix DNA breaks in our genome can impact our ability to enjoy a healthy life at an old age, as well as leave us vulnerable to neurological diseases like Motor Neurone Disease (MND)," saidProfessor Sherif El-Khamisy, Co-Founder and Deputy Director of the Healthy Lifespan Institute at the University of Sheffield and a professor from the Department of Molecular Biology and Biotechnology and the Neuroscience Institute at the University of Sheffield.

"We hope that by understanding how our cells fix DNA breaks, we can help meet some of these challenges, as well as explore new ways of treating cancer in the future."

Now, scientists hope they can use this new protein not only to protect us against aging andneurological diseases but also to find a new way to treat cancer.

"Our finding of TEX264, a protein that forms the specialized machinery to digest toxic proteins from our DNA, significantly changes the current understanding of how cells repair the genome and so protect us from accelerated ageing, cancer and neurodegeneration. I believe this discovery has a great potential for cancer therapy in the future and we are already pursuing our research in this direction," saidProfessor Kristijan Ramadan from the University of Oxford, who co-led the research.

What do you think of this new protein? A promising step toward a better, healthier life or another discovery that likely won't lead anywhere?

Excerpt from:
New Toolkit May Repair DNA Breaks Linked to Aging and Cancer - Interesting Engineering

Decoding the Future Trajectory of Healthcare with AI – ReadWrite

Artificial Intelligence (AI) is getting increasingly sophisticated day by day in its application, with enhanced efficiency and speed at a lower cost. Every single sector has been reaping benefits from AI in recent times. The Healthcare industry is no exception. Here is decoding the future trajectory of healthcare with AI.

The impact of artificial intelligence in the healthcare industry through machine learning (ML) and natural language processing (NLP) is transforming care delivery. Additionally, patients are expected to gain relatively high access to their health-related information than before through various applications such as smart wearable devices and mobile electronic medical records (EMR).

The personalized healthcare will authorize patients to take the wheel of their well-being, facilitate high-end healthcare, and promote better patient-provider communication to underprivileged areas.

For instance, IBM Watson for Health is helping healthcare organizations to apply cognitive technology to provide a vast amount of power diagnosis and health-related information.

In addition, Googles DeepMind Health is collaborating with researchers, clinicians, and patients in order to solve real-world healthcare problems. Additionally, the company has combined systems neuroscience with machine learning to develop strong general-purpose learning algorithms within neural networks to mimic the human brain.

Companies are working towards developing AI technology to solve several existing challenges, especially within the healthcare space. Strong focus on funding and starting AI healthcare programs played a significant role in Microsoft Corporations decision to launch a 5-year, US$ 40 million program known as AI for Health in January 2019.

The Microsoft program will use artificial intelligence tools to resolve some of the greatest healthcare challenges including global health crises, treatment, and disease diagnosis. Microsoft has also ensured that academia, non-profit, and research organizations have access to this technology, technical experts, and resources to leverage AI for care delivery and research.

In January 2020, these factors influenced Takeda Pharmaceuticals Company and MITs School of Engineering to join hands for three years to drive innovation and application of AI in the healthcare industry and drug development.

AI applications are only centered on three main investment areas: Diagnostics, Engagement, and Digitization. With the rapid advancement in technologies. There are exciting breakthroughs in incorporating AI in medical services.

The most interesting aspect of AI is robots. Robots are not only replacing trained medical staff but also making them more efficient in several areas. Robots help in controlling the cost while potentially providing better care and performing accurate surgery in limited space.

China and the U.S. have started investing in the development of robots to support doctors. In November 2017, a robot in China passed a medical licensing exam using only an AI brain. Also, it was the first-ever semi-automated operating robot that was used to suture blood vessels as fine as 0.03 mm.

In order to prevent coronavirus from spreading, the American doctors are relying on a robot that can measure the patients act and vitals. In addition, robots are also being used for recovery and consulting assistance and transporting units. These robots are showcasing significant potential in revolutionizing medical procedures in the future.

Precision medicine is an emerging approach to disease prevention and treatment. The precision medication approach allows researchers and doctors to predict more accurate treatment and prevention strategies.

The advent of precision medicine technology has allowed healthcare to actively track patients physiology in real-time, take multi-dimensional data, and create predictive algorithms that use collective learnings to calculate individual outcomes.

In recent years, there has been an immense focus on enabling direct-to-consumer genomics. Now, companies are aiming to create patient-centric products within digitization processes and genomics related to ordering complex testing in clinics.

In January 2020, ixLayer, a start-up based in San-Francisco, launched one of its kind precision health testing platforms to enhance the delivery of diagnostic testing and to shorten the complex relationship among physicians, precision health tests, and patients.

Personal health monitoring is a promising example of AI in healthcare. With the emergence of advanced AI and Internet of Medical Things (IoMT), demand for consumer-oriented products such as smart wearables for monitoring well-being is growing significantly.

Owing to the rapid proliferation of smart wearables and mobile apps, enterprises are introducing varied options to monitor personal health.

In October 2019, Gali Health, a health technology company, introduced its Gali AI-powered personal health assistant for people suffering from inflammatory bowel diseases (IBD). It offers health tracking and analytical tools, medically-vetted educational resources, and emotional support to the IBD community.

Similarly, start-ups are also coming forward with innovative devices integrated with state-of-the-art AI technology to contribute to the growing demand for personal health monitoring.

In recent years, AI has been used in numerous ways to support the medical imaging of all kinds. At present, the biggest use for AI is to assist in the analysis of images and perform single narrow recognition tasks.

In the United States, AI is considered highly valuable in enhancing business operations and patients care. It has the greatest impact on patient care by improving the accuracy of clinical outcomes and medical diagnosis.

Strong presence of leading market players in the country is bolstering the demand for medical imaging in hospitals and research centers.

In January 2020, Hitachi Healthcare Americas announced to start a new dedicated R&D center in North America. Medical imaging will leverage the advancements in machine learning and artificial intelligence to bring about next-gen of medical imaging technology.

With a plethora of issues driven by the growing rate of chronic disease and the aging population, the need for new innovative solutions in the healthcare industry is moving on an upswing.

Unleashing AIs complete potential in the healthcare industry is not an easy task. Both healthcare providers and AI developers together will have to tackle all the obstacles on the path towards the integration of new technologies.

Clearing all the hurdles will need a compounding of technological refinement and shifting mindsets. As AI trend become more deep-rooted, it is giving rise to highly ubiquitous discussions. Will AI replace the doctors and medical professionals, especially radiologists and physicians? The answer to this is, it will increase the efficiency of the medical professionals.

Initiatives by IBM Watson and Googles DeepMind will soon unlock the critical answers. However, AI aims to mimic the human brain in healthcare, human judgment, and intuitions that cannot be substituted.

Even though AI is augmenting in existing capabilities of the industry, it is unlikely to fully replace human intervention. AI skilled forces will swap only those who dont want to embrace technology.

Healthcare is a dynamic industry with significant opportunities. However, uncertainty, cost concerns, and complexity are making it an unnerving one.

The best opportunity for healthcare in the near future are hybrid models, where clinicians and physicians will be supported for treatment planning, diagnosis, and identifying risk factors. Also, with an increase in the number of geriatric population and the rise of health-related concerns across the globe, the overall burden of disease management has augmented.

Patients are also expecting better treatment and care. Due to growing innovations in the healthcare industry with respect to improved diagnosis and treatment, AI has gained consideration among the patients and doctors.

In order to develop better medical technology, entrepreneurs, healthcare service providers, investors, policy developers, and patients are coming together.

These factors are set to exhibit a brighter future of AI in the healthcare industry. It is extremely likely that there will be widespread use and massive advancements of AI integrated technology in the next few years. Moreover, healthcare providers are expected to invest in adequate IT infrastructure solutions and data centers to support new technological development.

Healthcare companies should continually integrate new technologies to build strong value and to keep the patients attention.

-

The insights presented in the article are based on a recent research study on Global Artificial Intelligence In Healthcare Market by Future Market Insights.

Abhishek Budholiya is a tech blogger, digital marketing pro, and has contributed to numerous tech magazines. Currently, as a technology and digital branding consultant, he offers his analysis on the tech market research landscape. His forte is analysing the commercial viability of a new breakthrough, a trait you can see in his writing. When he is not ruminating about the tech world, he can be found playing table tennis or hanging out with his friends.

See the original post here:
Decoding the Future Trajectory of Healthcare with AI - ReadWrite

Erasing Traumatic Memories May One Day Be Possible Thanks to New Discovery – SciTechDaily

The team found that flies kept in the dark were unable to maintain a pre-established long-term memory. This was due to the lack of Protein-dispersing factor (Pdf) release, which in turn results in no cAMP response element-binding protein (CREB) being produced in the memory center of the fly brain. Credit: Tokyo Metropolitan University

Environmental light shown to affect retention of traumatic long-term memory in flies.

Scientists from Tokyo Metropolitan University have discovered that Drosophila flies lose long-term memory (LTM) of a traumatic event when kept in the dark, the first confirmation of environmental light playing a role in LTM maintenance. The team also identified the specific molecular mechanism responsible for this effect. LTMs are notoriously difficult to erase; this work may lead to novel treatments for sufferers of trauma, perhaps even the erasure of life-altering traumatic memories.

It is impossible to remember everything that happens to us in a day. But a particularly shocking event may be consolidated into our long-term memory (LTM), whereby new proteins are synthesized and the neuronal circuits in our brain are modified. Such memories may be devastating to a victim, potentially triggering post-traumatic stress disorder (PTSD). Yet physiologically speaking, keeping a memory is far from a trivial process; active maintenance is required to keep the changes, protecting against the constant cellular rearrangement and renewal of a living organism. Despite the importance of understanding how memory works in the brain, the mechanism by which this occurs is not yet understood and is a key topic for neuroscience today.

It is well known that light, particularly the cycle of night and day, plays an important role in regulating animal physiology. Examples include circadian rhythm, mood and cognition. But how about long-term memory? Thus, a team led by Prof. Takaomi Sakai from Tokyo Metropolitan University set out to study how light exposure affects the memory of diurnal Drosophila fruit flies. As an instance of long-term memory or trauma, they used the courtship conditioning paradigm, where male flies are exposed to female flies which have already mated. Mated females are known to be unreceptive and exert a stress on male flies which fail to mate. Once the experience is committed to long-term memory, they no longer attempt to court female flies, even when the females around them are unmated.

The team found that conditioned male flies kept in the dark for 2 days or more no longer showed any reluctance to mate, while those on a normal day-night cycle did. This clearly shows that environmental light somehow modified the retention of LTM. This was not due to lack of sleep; flies on a diurnal cycle were slightly sleep deprived to match with flies in the dark, with no effect on the results. Thus, they focused on a protein in the brain called the Pigment-dispersing factor (Pdf), known to be expressed in response to light. For the first time, they found that Pdf regulated the transcription of a protein called the cAMP response element-binding protein (CREB) in the mushroom bodies, a part of the brain of insects known to be implicated in memory and learning. Thus, they identified the specific molecular mechanism by which light affects the retention of long-term memory.

Traumatic experiences are very difficult to forget and can severely impair a victims quality of life. But the teams discoveries show that these memories can, in fact, be significantly affected by environmental factors in living organisms. This opens up the exciting possibilities of new treatments for victims of trauma, perhaps even the ability to erase traumatic memories which prevent them from leading normal lives.

Reference: Environmental Light Is Required for Maintenance of Long-Term Memory in Drosophila by Show Inami, Shoma Sato, Shu Kondo, Hiromu Tanimoto, Toshihiro Kitamoto and Takaomi Sakai, 12 February 2020, Journal of Neuroscience.DOI: 10.1523/JNEUROSCI.1282-19.2019

This work was supported by JSPS KAKENHI Grant Numbers 18H04887 and 16H04816.

Read the original post:
Erasing Traumatic Memories May One Day Be Possible Thanks to New Discovery - SciTechDaily

Athlete Nia Lee sprints into action on the field and in the classroom – Rolling Out

Nia Lee of Romeoville, Illinois is a 20-year-old nationally ranked sprinter and long jumper at Illinois Wesleyan University. The accomplished athletes list of accomplishments inlcudes but is not limited to her track and field abilities. She is four-year track member; three-year cheer team member and earned All-State in the 41 relay. Lee has also earned Southwest Prairie All-Conference in the long jump, triple jump, and the 41 relay race.

Rolling out spoke with Lee regarding her athletic prowess on academic pursuits.

What does it mean to you to be named all conference?

What has long jumping taught you about yourself ?

Its taught me that the best is yet to come. Just when I think Im stuck jumping at a certain distance, Im able to prove myself wrong by jumping even further.

What is your major and why did you select it?

Im also interested in neuroscience because the brain is the most complex organ we have, and the blueprint for our behavior. Its interesting knowing what brain structures contribute to our actions, or how certain damages can lead to specific deficits.

What are you goals before graduation?

Before I graduate, I would like to get involved with some type of research at my university. My psychology program is filled with amazing professors who conduct their own unique research. I would like to gain experience getting involved in that before I graduate. I would also like to make the nationals for track.

Describe what lead you to be an entrepreneur?

I decided to pick up the skill of doing lashes because there are many different styles and looks to do. I like being able to make natural looks, making eyes more noticeable. Being able to make my own schedule and styles is also a plus.

What is your favorite hobby ?

My favorite hobby is definitely reading. If Im not reading, Im probably somewhere watching The Office.

What is it you enjoy about reading ?

Reading is definetly my escape. I love how Im able to travel without moving my feet. Im able to fall in love with different characters, and read from perspectives I typically wouldnt encounter.

Continued here:
Athlete Nia Lee sprints into action on the field and in the classroom - Rolling Out

Healing artist combines neuroscience and aesthetics in new collection – Winston-Salem Journal

When Dr. Renee Tegeler walked into her husbands new office, she knew she had to do something.

I realized his office space had nothing on the walls, she said.

As an healing artist meaning she makes art specifically for people who heal, such as doctors and therapists Tegeler was appalled by the lack of decoration. Dr. Charles Tegeler had been give the office last June when he was appointed the interim chair of the department of neurology at the Wake Forest School of Medicine.

So, the minute Tegeler retired on July 31, having worked as a doctor herself for almost 40 years, she began furiously working on art related to the brain, creating pieces for her husbands empty walls.

It looks much better now, Tegeler said, laughing.

Her brain-inspired work didnt stop there. Tegeler has created 72 pieces for her Neuroscience Collection, 46 of which are on display at the Keener Gallery in the Allegacy Headquarters through the end of the month.

This is Tegelers second show at the Keener Gallery, having displayed another collection there at the beginning of 2019.

For the Neuroscience Collection, Tegeler added new mediums to her repertoire, but most of the artwork involves fused glass.

Within the Neuroscience Collection is a mini-collection called Silhouette, a series of seven colored photographs of an original piece of fused-glass art. In it, a colorful brain sits inside an opaque profile of a head, created by fusing two layers of glass. The brain, also fused onto the head, was arranged with pieces of dichroic glass, a type of glass that transmits one color and reflects another color depending on the light.

Shes fusing glass in a way that no one else is doing, said Beth Blair, a massage therapist who helps run Tegelers gallery and gift shop. It mirrors the depth of a person, because it has layers.

The silhouette was then photographed on a piece of frosted glass through which a light was shone. To get each of the individual colors, ranging all the way down the rainbow from red to purple, Tegeler said she put different filters over the light for each photograph.

Her art is not only aesthetically pleasing but also scientific a challenge Tegeler felt prepared for with her strong background in medicine. This unique balance of neuroscience and art is best exemplified in a piece entitled The Neuron.

The Neuron differs from the rest of the collection by being the only non-brain image. Instead, this piece captures a snapshot of the inner workings of the brain: a neuron, with all the correct anatomical parts represented.

The purple cell body of the neuron, known as the soma, contains a pink nucleus in its center, and branch-like dendrites splay out from the soma. Across the middle of the piece, a thin black line, representing the axon and with a oval around each representing the protective myelin sheath, connects the soma to purple axon terminals with little synapses at their ends. Bright, multi-colored cells make up the background of the image.

Creating this image of the neuron happened almost purely by luck, since the materials Tegeler used alcohol ink on ceramic tile are hard to control. Instead of painting, she had to blow the ink to guide it into the correct formations. One wrong blow and the whole image would have been ruined.

Ill never do it again, Tegeler said, laughing. I tried to do a spinal cord or a brain. I decided to do a neuron, and that one worked.

With the Neuroscience Collection, Tegeler hopes to reach a new audience of doctors and therapists, healers of all kinds, who want to transform their office space with art.

Tegeler emphasized that by now focusing on healing art instead of medicine, she can doctor whole groups of people in lobbies and waiting rooms instead of just one person in an exam room. But at the end of the day, Tegeler believes its all worth it, if even just one person feels moved by her art.

If I can make that one person feel special, she said. That feeling brings me to my very core.

More here:
Healing artist combines neuroscience and aesthetics in new collection - Winston-Salem Journal

Quantum Death Human Cells Carry Quantum Information That Exists as a Soul (Weekend Feature) – The Daily Galaxy –Great Discoveries Channel

Posted on Mar 14, 2020 in Cosmology, Physics, Science

The physical universe that we live in is only our perception and once our physical bodies die, there is an infinite beyond. Some believe that consciousness travels to parallel universes after death. The beyond is an infinite reality that is much bigger which this world is rooted in. In this way, our lives in this plane of existence are encompassed, surrounded, by the afterworld already The body dies but the spiritual quantum field continues. In this way, I am immortal, suggest researchers from the Max Planck Institute for Physics in Munich

The Max Planck physicists are in agreement with British Physicist Sir Roger Penrose who argues that if a person temporarily dies, this quantum information is released from the microtubules and into the universe. However, if they are resuscitated the quantum information is channeled back into the microtubules and that is what sparks a near death experience. If theyre not revived, and the patient dies, its possible that this quantum information can exist outside the body, perhaps indefinitely, as a soul.

Steve Paulson writing for Nautil.us describes the 88-year-old Penroses theory as an audaciousand quite possibly crackpottheory about the quantum origins of consciousness. He believes we must go beyond neuroscience and into the mysterious world of quantum mechanics to explain our rich mental life. No one quite knows what to make of this theory, developed with the American anesthesiologist Stuart Hameroff, but conventional wisdom goes something like this: Their theory is almost certainly wrong, but since Penrose is so brilliant (One of the very few people Ive met in my life who, without reservation, I call a genius, physicist Lee Smolin has said), wed be foolish to dismiss their theory out of hand.

While scientists are still in heated debates about what exactly consciousness is, the University of Arizonas Hameroff and Penrose conclude that it is information stored at a quantum level. Penrose agrees he and his team have found evidence that protein-based microtubulesa structural component of human cellscarry quantum information information stored at a sub-atomic level.

It was Hameroffs idea, writes Paulson, that quantum coherence happens in microtubules, protein structures inside the brains neurons. And what are microtubules, you ask? They are tubular structures inside eukaryotic cells (part of the cytoskeleton) that play a role in determining the cells shape, as well as its movements, which includes cell divisionseparation of chromosomes during mitosis. Hameroff suggests that microtubules are the quantum device that Penrose had been looking for in his theory. In neurons, microtubules help control the strength of synaptic connections, and their tube-like shape might protect them from the surrounding noise of the larger neuron. The microtubules symmetry and lattice structure are of particular interest to Penrose. He believes this reeks of something quantum mechanical.

Somehow, our consciousness is the reason the universe is here, Penrose told Paulson during an interview. Theres intelligent lifeor consciousnesssomewhere else in the cosmos, Penrose added. But it may be extremely rare. But if consciousness is the point of this whole shebang, wouldnt you expect to find some evidence of it beyond Earth Paulson asked? Well, Im not so sure our own universe is that favorably disposed toward consciousness, Penrose replied.

In Beyond Biocentrism: Rethinking Time, Space, Consciousness, and the Illusion of Death, Robert Lanza asks does the soul exist? The new scientific theory he propounds says were immortal and exist outside of time. Biocentrism postulates that space and time are not the hard objects we think. Death does not exist in a timeless, spaceless world. His new scientific theory suggests that death is not the terminal event we think.

There are an infinite number of universes, and everything that could possibly happen occurs in some universe. Death does not exist in any real sense in these scenarios. All possible universes exist simultaneously, regardless of what happens in any of them. Although individual bodies are destined to self-destruct, the alive feelingthe Who am I?- is just a 20-watt fountain of energy operating in the brain. But this energy doesnt go away at death. One of the surest axioms of science is that energy never dies; it can neither be created nor destroyed. But does this energy transcend from one world to the other?

The Daily Galaxy, Max Goldberg, via Nautil.us, Robert Lanza and Sunday Guardian Live

Image credit: via Pixabay

Read this article:
Quantum Death Human Cells Carry Quantum Information That Exists as a Soul (Weekend Feature) - The Daily Galaxy --Great Discoveries Channel

Alzheimer’s Brains Short Circuited by Defective Protein Connections – Genetic Engineering & Biotechnology News

In many respects, the brain is a black box. The organ where our knowledge is derived is, ironically, also the one where much of the knowledge for its inner workings are lacking. However, researchers have devoted their lives to understanding the enigmatic organ and work tirelessly to prevent diseases that deprive it of its primary functions. For instance, new research from a team of investigators led by scientists at Memorial Sloan Kettering (MSK) has uncovered new findings that show how stress-induced changes in protein connections in the brain contribute to the cognitive decline seen in Alzheimers disease (AD).

Amazingly, the researchers were able to reverse this malfunctioning protein network and its associated cognitive decline in mice, using an experimental drug. Findings from the new studypublished recently in Nature Communications through an article entitled The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunctionsuggest a new way to look at how Alzheimers develops in the brain by focusing on protein networks.

The research team used laboratory, mouse, and brain-tissue studies to examine the epichaperomea dysregulated network of proteins that affects how cells communicate and accelerate the course of disease.

To find out why epichaperomes were prevalent in Alzheimers, we used a new omics method, we call chaperomics, that allows us to assess functional outcomes of connectivity changes between normal individuals and those with Alzheimers, explained senior study investigator Gabriela Chiosis, PhD, a professor in the department of molecular pharmacology and chemistryat MSK. This new technology has a profound capacity for high throughput. Although chaperomics generates massive datasets, Chiosis states data analysis is meant to be readily accessible, indicating The bioinformatics platforms are straightforward and easy to comprehend, rather than adding additional complexity to these large protein connectivity-based results.

Various stressorssuch as genetic risk factors, vascular injury, and diabetescan damage brain circuitry in AD. According to this new study, these stressors seem to interact with proteins and contribute to toxic changes that begin in the hippocampus, a brain region involved in learning and memory. The researchers explored how these protein networks stop working properly and can be restored.

We used cellular and animal models as well as human biospecimens to show that AD-related stressors mediate global disturbances in dynamic intra- and inter-neuronal networks through pathologic rewiring of the chaperome system into epichaperomes, the authors wrote. These structures provide the backbone upon which proteome-wide connectivity, and in turn, protein networks become disturbed and ultimately dysfunctional.

Much like faulty wires in a circuit board that lead to network failure, epichaperomes seem to remodel cellular processes that, in turn, rewire protein connections supporting normal brain function. The resulting imbalance in brain circuitrywhich the authors call protein connectivity-based dysfunctionunderlies synaptic failure and other neurodegenerative processes. The researchers studied a cellular model of Alzheimers and a mouse model of the protein tau, as well as human brain tissue, which showed significantly more epichaperomes in individuals who had Alzheimers than in cognitively healthy people.

Based on their discoveries, Chiosis and her colleagues developed a new term to describe this phenomenonprotein connectivitybased dysfunction or PCBD. Many people who study Alzheimers are thinking about circuits in the brain. But theres no clear understanding of how stressors due to aging and the environment change the way proteins interact, noted collaborating scientist and study co-author Stephen Ginsberg, PhD, an associate professor at the Center for Dementia Research at the Nathan Kline Institute and departments of psychiatry, neuroscience & physiology and the NYU neuroscience institute at the NYU School of Medicine. Our research demonstrates that epichaperome formation rewires brain circuitry in Alzheimers by enabling proteins to misconnect, leading to downstream PCBD and cognitive decline.

In the current study, the research team treated young and old mice bred to have Alzheimers with an epichaperome inhibitor they developed, called PU-AD, three times per week for three to four months. The treated mice performed better on memory and learning tests than untreated mice had less tau (a protein seen in AD) and survived longer. Whats more, their brains looked like those of normal mice. PU-AD inhibited the faulty protein networks created by epichaperomes by correcting how the proteins connected and promoting nerve-cell survival.

We show at cellular and target organ levels that network connectivity and functional imbalances revert to normal levels upon epichaperome inhibition, the authors concluded. We provide proof-of-principle to propose AD is a PCBDopathy, a disease of proteome-wide connectivity defects mediated by maladaptive epichaperomes.

Visit link:
Alzheimer's Brains Short Circuited by Defective Protein Connections - Genetic Engineering & Biotechnology News

Research Roundup: Higher Coronavirus Infections Than Estimated and More – BioSpace

Every week there are numerous scientific studies published. Heres a look at some of the more interesting ones.

COVID-19 Infections in U.S. Likely to Be Much Higher Than Previously Suspected

Perhaps not surprisingly, given recent coverage, a study out of Cedars-Sinai Medical Center projected that as of March 1, 2020, thousands more people in the U.S. were likely infected by the coronavirus that causes COVID-19 than was initially reported. Some of this initial underestimate is associated with the overall lack of laboratory testing for the virus. As of March 11, 1,323 cases have been confirmed in the U.S., according to Johns Hopkins University. The Cedars-Sinai investigators chose very conservative methods to estimate the number of cases, which, they wrote in their study published in medRxiv, This makes our current estimation likely to be an underestimation of the true number of infected individuals in the U.S.

The team modeled COVID-19 coronavirus cases imported directly to the U.S. from the Wuhan, China area before January 23, which is when the Chinese government locked down the city. They did not include potential cases from other parts of China or other countries, such as South Korea, Italy or Iran, which have also seen major spikes in cases. They then calculated the scale of COVID-19 in the U.S. based on air traffic data between Wuhan and the U.S., totals of publicly released confirmed cases by the U.S. Centers for Disease Control and Prevention (CC), and transmission dynamics estimated from earlier research. It also took into consideration the identification and quarantine of individual domestic cases in the U.S. As of March 1, they projected the number of people infected in the U.S. to be between 1,043 and 9.484. The lower number assumes current preventive procedures like quarantines and airport screening decreases transmissibility by as much as 25%. The second figure assumes no intervention procedures had been performed to decrease transmissibility.

Although it would be easy to take this study as a very pessimistic conclusion, the authors say it suggests that aggressive containment and preventive measures can have a big effect in controlling the outbreak.

Our model suggests that even moderately effective population interventions to reduce transmission can have a profound impact on the scale of the epidemic, said Dermot P. McGovern, professor of Medicine and Biomedical Sciences at Cedars-Sinai and senior author of the study. This finding supports the role of public health interventions in controlling this disease.

Experimental Fibrosis Drug Could Make Immunotherapy Better

Researchers at the University of Southampton, funded by Cancer Research UK, demonstrated that an experimental drug being developed by Frances Genkyotex called setanaxib may help immunotherapy drugs infiltrate tumors better. The drug is being investigated in clinical trials in diabetic kidney disease (DKD), idiopathic pulmonary fibrosis (IPF) and primary biliary cholangitis (PBC). But researchers theorized that the drug might be able to clear cancer-associated fibroblasts (CAF) that often surround tumors, making cancer cells more accessible by immune cells. Their research into mouse tumors appears to support their theory.

Scorpion-Derived Proteins Delivery Arthritis Drugs

Researchers at the Fred Hutchinson Cancer Research Center identified a small protein in scorpion venom that quickly accumulates in joint cartilage. They linked these proteins with steroids to reverse inflammation in laboratory animals with arthritis. Because the drugs concentrated in the joints, they avoided the systemic toxicity associated with the steroids and infection risks caused by nontargeted steroid treatments.

2-Hour Salmonella Testing

Cornell University investigators developed a method for whole-genome sequencing that can identify salmonella serotypes in about two hours and the entire identification process in eight hours. Determining salmonellas serotype helps find the source of bacterial contamination. There are 38 salmonella strains, accounting for 34 serotypes, that were assessed in the study.

Low Blood Pressure in the Elderly Associated with Higher Mortality

A major study of 415,980 medical records of older adults in England found that people 75 years of age or older with low blood pressure, meaning below 130/80, had increased mortality rates compared to those with normal blood pressure. This was particularly significant in so-called frail patients, who had 62% increased risk of death during the 10-year follow-up. High blood pressure increased the risk of cardiovascular incidents like heart attacks but was not linked to higher mortality in frail adults over 75.

The Real Reason Men Die Earlier Than Women

One rationale for men dying younger than women has typically been the argument that men take more risks, have more dangerous jobs, drink and smoke more, and delay seeing the doctor. New research suggests the real reason is less behavioral and more biologicaland related to the Y chromosome. Women have no Y chromosome, instead having two X chromosomes; men have an X and a Y chromosome. They found that across species that have XY (male) and XX (female), the females live longer, with the males dying 17.6% earlier on average. At least part of the reason appears to be the unguarded X hypothesis, which suggests that the XY is less able to protect an individual from harmful genes on the X chromosome than in XX females, where the second X can shield the female from some genetic defects.

Protein IDed to Help Wound Healing After Spinal Cord Injury

Researchers at Mount Sinai Hospital and Mount Sinai School of Medicine identified plexin-B2, an axon guidance protein in the central nervous system (CNS) as being critical in wound healing and neural repair after spinal cord injury. They believe the research could lead to the development of treatments for spinal cord injury patients. The research was published in the journal Nature Neuroscience.

The role of microglia and macrophages in the spatial organization of glial cells around the injury site via an axon guidance receptor is quite unexpected, said Hongyan Jenny Zou, professor of Neurosurgery and Neuroscience at the Icahn School of Medicine at Mount Sinai.

CNS tissue repair requires a coordinated response from diverse cell types in overlapping phases. Before this, astrocytes were presumed to be the main driver for the organization of various responses. But this study found that Plexin-B2 was the main driver of injury-activated microglia/macrophages.

Continue reading here:
Research Roundup: Higher Coronavirus Infections Than Estimated and More - BioSpace